Hayek Kallen Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$165K |
| 2 |
Cisco
CSCO
|
+$62.9K |
| 3 |
Starbucks
SBUX
|
+$30.5K |
| 4 |
SLB Ltd
SLB
|
+$25.5K |
| 5 |
AT&T
T
|
+$21.7K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$2.14M |
| 2 |
McDonald's
MCD
|
+$1.26M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$630K |
| 4 |
Icon
ICLR
|
+$414K |
| 5 |
AstraZeneca
AZN
|
+$211K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.71% |
| 2 | Technology | 19.58% |
| 3 | Consumer Staples | 17.33% |
| 4 | Industrials | 10.02% |
| 5 | Financials | 9.25% |
Similar funds
Hayek Kallen Investment Management's Q3 2017 Portfolio in Review
As of Q3 2017, Hayek Kallen Investment Management held 68 positions worth $146M, down 1.3% from $148M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Hayek Kallen Investment Management withdrew a net $6.55M in Q3 2017, closing 4 positions and reducing 39 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $2.14M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Hayek Kallen Investment Management added an estimated $165K to Wells Fargo.
- Hayek Kallen Investment Management added most to Wells Fargo in Q3 2017, an estimated $165K increase.
- Hayek Kallen Investment Management's biggest Q3 2017 reduction was McDonald's, cutting an estimated $1.26M.
- Hayek Kallen Investment Management fully exited Teva Pharmaceuticals in Q3 2017, selling an estimated $2.14M.
- Hayek Kallen Investment Management's ten largest holdings make up 39% of its $146M portfolio in Q3 2017.
- Hayek Kallen Investment Management opened 0 new positions and closed 4 in Q3 2017.
- Hayek Kallen Investment Management's portfolio value fell 1.3% quarter-over-quarter to $146M.
Based on Hayek Kallen Investment Management's 13F filing for Q3 2017, filed 25 Oct 2017.